“Incurable” Advanced NSCLC to Active Lifestyle
A Stage IV non-small cell lung cancer diagnosis at age 42 surprised Anne P., a never-smoker and mother of two. Thanks to comprehensive genomic tumor testing, she now uses targeted therapy for her EGFR- and T790M-positive lung tumors, maintaining an active life and raising awareness about lung cancer research.
“Incurable” Advanced NSCLC to Active Lifestyle Read More »